Genetic variants in caspase genes and susceptibility to non-Hodgkin lymphoma

Qing Lan, Tongzhang Zheng, Stephen Chanock, Yawei Zhang, Min Shen, Sophia S. Wang, Sonja I. Berndt, Shelia H. Zahm, Theodore R. Holford, Brian Leaderer, Meredith Yeager, Robert Welch, Dean Hosgood, Peter Boyle, Nathaniel Rothman

Research output: Contribution to journalArticlepeer-review

64 Scopus citations


The caspase proteins are essential for the regulation of normal B cell development and regulation of apoptosis. We investigated five single nucleotide polymorphisms in four key caspase genes, CASP3 [Ex8-280C>A (rs6948) and Ex8+567T>C (rs1049216)], CASP8 Ex14-271A>T (rs13113), CASP9 Ex5+32G>A (rs1052576) and CASP10 Ex3-171A>G (rs3900115) to determine whether they alter risk for non-Hodgkin lymphoma (NHL) in a population-based case-control study of women in Connecticut (461 cases and 535 controls). Variants in CASP3 and CASP9 were significantly associated with a decreased risk for NHL, particularly follicular lymphoma [e.g. CASP3 Ex8+567T>C odds ratio (OR) CC+TC = 0.4, 95% confidence interval (CI) = 0.3-0.7; and CASP9 Ex5+32G>A OR AA+AG = 0.6, 95% CI = 0.4-1.0]. Further, variants in CASP3, CASP8 and CASP10 were associated with a decreased risk of marginal zone lymphoma and variants in CASP3 and CASP10 were associated with a lower risk of chronic lymphocytic leukemia and related subtypes. The striking protective associations observed for polymorphisms in all four genes for NHL and/or one or more subtypes suggest that genetic variation in CASP genes may play an important role in the etiology of NHL.

Original languageEnglish (US)
Pages (from-to)823-827
Number of pages5
Issue number4
StatePublished - Apr 2007
Externally publishedYes

ASJC Scopus subject areas

  • Cancer Research


Dive into the research topics of 'Genetic variants in caspase genes and susceptibility to non-Hodgkin lymphoma'. Together they form a unique fingerprint.

Cite this